Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 2,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
The American Journal of Clinical Nutrition, 2021Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic
Cauwenberghs N., Prunicki M., Sabovčik F. et al.
Olink Target 96
EP Europace, 2021Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies
De With R., Artola Arita V., Nguyen B. et al.
eClinicalMedicine, 2021Acute effects of dapagliflozin on renal oxygenation and perfusion in type 1 diabetes with albuminuria: A randomised, double-blind, placebo-controlled crossover trial
Laursen J., Søndergaard-Heinrich N., de Melo J. et al.
Journal of Personalized Medicine, 2021Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
Guldvik I., Ekseth L., Kishan A. et al.
ESC Heart Failure, 2021Identification of sex‐specific biomarkers predicting new‐onset heart failure
Raafs A., Verdonschot J., Ferreira J. et al.
Journal of Cachexia, Sarcopenia and Muscle, 2021Proteomic profiling of low muscle and high fat mass: a machine learning approach in the KORA S4/FF4 study
Huemer M., Bauer A., Petrera A. et al.
Clinical Chemistry and Laboratory Medicine (CCLM), 2021Novel severe traumatic brain injury blood outcome biomarkers identified with proximity extension assay
Fraser D., Chen M., Ren A. et al.
Journal of Allergy and Clinical Immunology, 2021Convergence of cytokine dysregulation and antibody deficiency in common variable immunodeficiency with inflammatory complications
Abyazi M., Bell K., Gyimesi G. et al.
Journal of the American Society of Nephrology, 2021Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
Matías-García P., Wilson R., Guo Q. et al.
Journal of Cancer Research and Clinical Oncology, 2021Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma
Camargo M., Song M., Ito H. et al.
Nature Communications, 2021The geometry of clinical labs and wellness states from deeply phenotyped humans
Zimmer A., Korem Y., Rappaport N. et al.
Biofabrication, 2021Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells
Drzeniek N., Mazzocchi A., Schlickeiser S. et al.
Science Translational Medicine, 2021Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
Reyes M., Filbin M., Bhattacharyya R. et al.
Olink Explore 3072/384
Cell Discovery, 2021Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19
Tan Y., Zhang W., Zhu Z. et al.
PLOS ONE, 2021Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Kragstrup T., Singh H., Grundberg I. et al.
Nephrology Dialysis Transplantation, 2021Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis
Wu P., Glerup R., Svensson M. et al.
Leukemia, 2021STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
Kim D., Park G., Huuhtanen J. et al.
Journal of Urology, 2021Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer
Lifshitz K., Ber Y., Shenhar C. et al.
Alzheimer's & Dementia, 2021Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
Jiang Y., Zhou X., Ip F. et al.
Journal of the American Academy of Dermatology, 2021Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement
Dubin C., Glickman J., Del Duca E. et al.
2821 publications
Items per page
1841-1860 of 2821 publications